Karen Velastegui
Karen Velastegui publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations and Cancer Treatment and Pharmacology.
- World rank
- #374,634 of 7,710,434 ranked researchers
- Rank in United States
- #133,552 of 1,627,098
- Works
- 126
- Citations
- 3.1k
- Citations per work
- 24.3
What does Karen Velastegui research?
Karen Velastegui's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8869.6%
- Medicine8869.6%
- Everything else1713.1%
- Life Sciences1613.0%
- Social Sciences54.3%
- 1Oncology52% of their works
- 2Pulmonary and Respiratory Medicine17% of their works
- 3Molecular Biology9% of their works
- 4Immunology4% of their works
- 5Economics and Econometrics3% of their works
- 6Sociology and Political Science1% of their works
Research topics
Which keywords describe Karen Velastegui's research?
The keywords of their largest research topics: Chemotherapy, Cetuximab, KRAS Mutations, EGFR Mutations, Targeted Therapy, Tumor Microenvironment, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- apoptotic cells
- Protein Kinases
- Surgical Complications
- PD-1 and PD-L1
- HER2
- Taxanes
- Tumor Microenvironment
- EGFR Mutations
- Cetuximab
- Chemotherapy
- KRAS Mutations
- Targeted Therapy
- Chemotherapy-Induced Peripheral Neuropathy
- Breast Cancer
- Immune Checkpoint Blockade
- Pancreatic Cancer
- CD47
- Ras Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Chemotherapy213 topics
- Cetuximab131 topic
- KRAS Mutations131 topic
- EGFR Mutations81 topic
- Targeted Therapy81 topic
- Tumor Microenvironment82 topics
- Chemotherapy-Induced Peripheral Neuropathy51 topic
- Taxanes51 topic
- Breast Cancer41 topic
- HER241 topic
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
- Pancreatic Cancer41 topic
- Surgical Complications41 topic
- CD4731 topic
- Protein Kinases31 topic
- Ras Signaling31 topic
- apoptotic cells31 topic
Where does Karen Velastegui work?
Karen Velastegui's main affiliation in the publication record is Mirati Therapeutics (United States), United States.
How many publications and citations does Karen Velastegui have?
OpenAlex counts 126 works and 3,063 citations for Karen Velastegui, an h-index of 16, ranking #374,634 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Karen Velastegui. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.